Arrowhead Pharmaceuticals Inc (ARWR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Arrowhead Pharmaceuticals Inc Azioni (ARWR) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	2.06% 75.25	73.74	264.03	256.47	27.77
Operating Expenses	14.12% 245.35	215.00	223.22	212.37	193.32
Depreciation and Amortization	4.57% 6.659	6.368	6.39	6.386	6.223
Operating Income/Loss	20.41% -170.09	-141.26	40.81	44.11	-165.55
Nonoperating Income/Loss	338.48% -8.812	3.695	-12.54	-7.985	-13.54
Income/Loss From Equity Method Investments	63.24% -2.47	-6.719	-	-	-
Income/Loss From Continuing Operations Before Tax	30.05% -178.91	-137.56	28.27	36.12	-179.09
Income Tax Expense/Benefit	57.14% 0.011	0.007	0.029	20.00	-0.437
Net Income/Loss	30.05% -178.92	-137.57	28.24	16.12	-178.65
Attributable To Noncontrolling Interest	417.44% 15.36	-4.84	-2.569	39.87	-3.411
Basic Average Shares	0.67% 143.38	142.42	137.04	1.373	139.04
Diluted Average Shares	0.67% 143.38	142.42	140.71	0.406	139.04
Basic Earnings Per Share	46.24% -1.36	-0.93	0.22	-0.18	-1.26
Diluted Earnings Per Share	46.24% -1.36	-0.93	0.22	-0.18	-1.26